Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials

A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sergey V. Kakorin, Ruben A. Iskandaryan, Ashot M. Mkrtumyan
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb8f588030c447b9920ad02bf807fdf2
record_format dspace
spelling oai:doaj.org-article:bb8f588030c447b9920ad02bf807fdf22021-11-14T09:00:20ZPerspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials2072-03512072-037810.14341/DM200412-6https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf22016-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7563https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM and those with normal carbohydrate metabolism. These treatments increase the life expectancy and greatly improve the quality of life of patients with acute myocardial infarction in both groups of patients. However, the risk of cardiovascular mortality in patients with T2DM compared with people with normal carbohydrate metabolism remains unchanged. The rapidly growing population of patients with T2DM will soon change our attitude towards the possibility of improving the prognosis and treatment of those with CVD.Sergey V. KakorinRuben A. IskandaryanAshot M. MkrtumyanEndocrinology Research Centrearticletype 2 diabetes mellituschronic heart failurecardiovascular mortalityhyperglycemiaglycated hemoglobininsulin resistancerisk factorsepidemiology of cardiovascular diseaseNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 2, Pp 141-149 (2016)
institution DOAJ
collection DOAJ
language EN
RU
topic type 2 diabetes mellitus
chronic heart failure
cardiovascular mortality
hyperglycemia
glycated hemoglobin
insulin resistance
risk factors
epidemiology of cardiovascular disease
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle type 2 diabetes mellitus
chronic heart failure
cardiovascular mortality
hyperglycemia
glycated hemoglobin
insulin resistance
risk factors
epidemiology of cardiovascular disease
Nutritional diseases. Deficiency diseases
RC620-627
Sergey V. Kakorin
Ruben A. Iskandaryan
Ashot M. Mkrtumyan
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
description A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM and those with normal carbohydrate metabolism. These treatments increase the life expectancy and greatly improve the quality of life of patients with acute myocardial infarction in both groups of patients. However, the risk of cardiovascular mortality in patients with T2DM compared with people with normal carbohydrate metabolism remains unchanged. The rapidly growing population of patients with T2DM will soon change our attitude towards the possibility of improving the prognosis and treatment of those with CVD.
format article
author Sergey V. Kakorin
Ruben A. Iskandaryan
Ashot M. Mkrtumyan
author_facet Sergey V. Kakorin
Ruben A. Iskandaryan
Ashot M. Mkrtumyan
author_sort Sergey V. Kakorin
title Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
title_short Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
title_full Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
title_fullStr Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
title_full_unstemmed Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
title_sort perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
publisher Endocrinology Research Centre
publishDate 2016
url https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf2
work_keys_str_mv AT sergeyvkakorin perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials
AT rubenaiskandaryan perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials
AT ashotmmkrtumyan perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials
_version_ 1718429553500618752